Related Experiment Video

Updated: May 10, 2026

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
10:02

Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

Published on: March 12, 2020

Evidence for efficacy of neurofeedback in ADHD?

Martijn Arns, Ute Strehl

    The American Journal of Psychiatry
    |July 4, 2013
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
    13:09

    Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol

    Published on: April 1, 2018

    A Protocol for the Administration of Real-Time fMRI Neurofeedback Training
    07:05

    A Protocol for the Administration of Real-Time fMRI Neurofeedback Training

    Published on: August 24, 2017

    Related Experiment Videos

    Last Updated: May 10, 2026

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
    10:02

    Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)

    Published on: March 12, 2020

    Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
    13:09

    Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol

    Published on: April 1, 2018

    A Protocol for the Administration of Real-Time fMRI Neurofeedback Training
    07:05

    A Protocol for the Administration of Real-Time fMRI Neurofeedback Training

    Published on: August 24, 2017

    Related Concept Videos

    Attention-Deficit/Hyperactivity Disorder01:30

    Attention-Deficit/Hyperactivity Disorder

    Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
    Diagnostic Criteria and Symptoms
    To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.

    Articles linked to this work by shared authors, journal, and citation graph.

    Baseline inflammatory profiles in moderate-to-severe depression and differential response to intermittent theta-burst stimulation.

    Progress in neuro-psychopharmacology & biological psychiatry·2026

    Pilot randomized trial of intermittent theta-burst stimulation versus H-Coil transcranial magnetic stimulation for treatment-resistant depression.

    Psychiatry research·2026

    No Effects of rTMS on Performance Monitoring and Attentional Bias in Patients With Alcohol Use Disorder: A Pilot Study.

    Addiction biology·2025

    Comparison of 5-Day Multidaily Neuronavigated Theta-Burst Sessions With 6-Week Standard Repetitive Transcranial Magnetic Stimulation (the Dutch Depression Outcome Trial): Protocol for a Randomized Controlled Trial.

    JMIR research protocols·2025

    Prediction of response to transcranial magnetic stimulation treatment for depression using EEG and machine learning.

    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2025

    Trigeminal nerve stimulation as an active control condition in TMS clinical trials: Evidence from heart-brain coupling and clinical outcomes.

    Brain stimulation·2025

    The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions.

    The American journal of psychiatry·2026

    Hippocampal Dentate Gyrus Plasticity and Its Association With Dimensional Clinical Improvement Across Four Depression Treatment Interventions.

    The American journal of psychiatry·2026

    Association Between Age-Dependent DNA Methylation Changes at FKBP5 Enhancer Sites and Increased Cortical Gene Expression in Schizophrenia.

    The American journal of psychiatry·2026

    Youth Autistic Traits and Brain Activation States During Socioemotional Processing.

    The American journal of psychiatry·2026

    Individualized Connectivity-Guided Versus Conventional Targeting of Accelerated Theta-Burst Stimulation in Depression: A Randomized, Double-Blind, Parallel-Design Trial.

    The American journal of psychiatry·2026

    Schizophrenia Beyond Genome-Wide Association Studies: It's About Time.

    The American journal of psychiatry·2026

    Use of High-Flow Nasal Cannula in Amyotrophic Lateral Sclerosis Patients Intolerant to Non-Invasive Ventilation: A Case Series.

    Respirology case reports·2026

    A potential therapeutic role of unilateral anterior thalamic deep brain stimulation in epileptic spasms: A case report.

    Epilepsy & behavior reports·2026

    Gastric amyloid pathology and mucosal denervation in ATTRv amyloidosis: insights from patients, mice, and gut microenvironment profiles.

    Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2026

    The brain angiotensin converting enzyme 2 and angiotensin-(1-7) as potential therapeutic targets for the central nervous system diseases.

    Pharmacology & therapeutics·2026

    Alterations in glymphatic system-related MRI markers in patients with primary restless legs syndrome and association with disease severity.

    Sleep medicine·2026

    Plasma NET-associated readouts and a multidomain neuroimmune injury axis after experimental subarachnoid hemorrhage: response to dual-pathway modulation.

    Journal of neuroimmunology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us